NCT00583765 - Evaluation of a Simplified Protocol for Regional Citrate Anticoagulation in Continuous Venovenous Hemodiafiltration | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions

Kidney Failure, Acute

Interventions

DRUG

Regional citrate anticoagulation

Continuous venovenous hemodiafiltration with regional anticoagulation using dilute trisodium citrate. This requires the use of a continuous renal replacement therapy (CRRT) machine in venovenous hemodiafiltration mode. Anticoagulation and buffer are provided by the use of a dilute solution of trisodium citrate in the replacement fluid which is infused in a predilution mode. Standard bicarbonate containing dialysate is used.

Trial Locations (1)

T6G 2B7

General Systems Intensive Care Unit, University of Alberta Hospital, Edmonton

All Listed Sponsors

collaborator

Gambro Renal Products, Inc.

INDUSTRY

lead

University of Alberta

OTHER